ES2137549T3 - Derivados antifungicos de sordaridina. - Google Patents

Derivados antifungicos de sordaridina.

Info

Publication number
ES2137549T3
ES2137549T3 ES95938406T ES95938406T ES2137549T3 ES 2137549 T3 ES2137549 T3 ES 2137549T3 ES 95938406 T ES95938406 T ES 95938406T ES 95938406 T ES95938406 T ES 95938406T ES 2137549 T3 ES2137549 T3 ES 2137549T3
Authority
ES
Spain
Prior art keywords
sordaridine
antifungal
derivatives
antifungal derivatives
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95938406T
Other languages
English (en)
Inventor
Jose Ramon Ruiz Gomez
Jose Maria Bueno Calderon
Dorado Silvestre Garcia-Ochoa
Gabaldon Maria Teresa G Fraile
Julia Castro Pichel
Roman Jose Fiandor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Wellcome SA
Original Assignee
Glaxo Wellcome SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP94500175A external-priority patent/EP0711784A1/en
Priority claimed from EP94500173A external-priority patent/EP0712859A1/en
Application filed by Glaxo Wellcome SA filed Critical Glaxo Wellcome SA
Application granted granted Critical
Publication of ES2137549T3 publication Critical patent/ES2137549T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Abstract

UN COMPUESTO REPRESENTADO POR LA FORMULA (I), EN DONDE Z ES UN GRUPO TETRAHIDROPIRANO SELECCIONADO ENTRE (A) Y (B), QUE TIENE ACTIVIDAD ANTIFUNGICA, PROCESOS PARA SU PREPARACION Y SU USO EN MEDICINA.
ES95938406T 1994-11-08 1995-11-06 Derivados antifungicos de sordaridina. Expired - Lifetime ES2137549T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94500175A EP0711784A1 (en) 1994-11-08 1994-11-08 Antifungal Sordarin derivatives
EP94500173A EP0712859A1 (en) 1994-11-08 1994-11-08 Antifungal Sordarin derivatives

Publications (1)

Publication Number Publication Date
ES2137549T3 true ES2137549T3 (es) 1999-12-16

Family

ID=26137608

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95938406T Expired - Lifetime ES2137549T3 (es) 1994-11-08 1995-11-06 Derivados antifungicos de sordaridina.

Country Status (35)

Country Link
US (2) US5854280A (es)
EP (1) EP0753001B1 (es)
JP (1) JPH09508144A (es)
KR (1) KR100391401B1 (es)
CN (1) CN1056849C (es)
AP (1) AP614A (es)
AR (1) AR013815A1 (es)
AT (1) ATE184284T1 (es)
AU (1) AU704405B2 (es)
BG (1) BG62620B1 (es)
BR (1) BR9506473A (es)
CA (1) CA2179403A1 (es)
CO (1) CO4520226A1 (es)
CZ (1) CZ202796A3 (es)
DE (1) DE69512041T2 (es)
DK (1) DK0753001T3 (es)
EE (1) EE9600117A (es)
ES (1) ES2137549T3 (es)
FI (1) FI962773A (es)
GR (1) GR3031677T3 (es)
HK (1) HK1004222A1 (es)
HU (1) HU218611B (es)
IL (1) IL115905A0 (es)
IS (1) IS4352A (es)
MX (1) MX9602563A (es)
NO (1) NO307092B1 (es)
NZ (1) NZ296091A (es)
OA (1) OA10303A (es)
PE (1) PE49696A1 (es)
RU (1) RU2152398C1 (es)
SI (1) SI0753001T1 (es)
SK (1) SK88496A3 (es)
TW (1) TW321644B (es)
WO (1) WO1996014326A1 (es)
ZA (1) ZA959362B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177457B1 (en) * 1996-05-08 2001-01-23 Glaxo Wellcome S.A. Process for the preparation of indacene compound
US6436395B1 (en) 1996-09-18 2002-08-20 Merck & Co., Inc. Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control
US6040463A (en) * 1996-10-07 2000-03-21 Merck & Co., Inc. Sordarin derivatives
US6096511A (en) * 1997-06-10 2000-08-01 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
US5972996A (en) * 1997-08-22 1999-10-26 Merck & Co., Inc. 4-cyano-4-deformylsordarin derivatives
US5965612A (en) * 1997-08-22 1999-10-12 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives
JP4339505B2 (ja) * 1997-08-22 2009-10-07 メルク エンド カムパニー インコーポレーテッド ４−シアノ−４−デホルミルソルダリン誘導体
US6136853A (en) * 1997-10-03 2000-10-24 Merck & Co., Inc. Sordarin derivatives
FI974385A0 (fi) 1997-12-01 1997-12-01 Xyrofin Oy Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
US7070965B1 (en) * 1998-04-14 2006-07-04 Zhenhua Yang Small molecule anticancer compounds and related production process
MA26628A1 (fr) * 1998-05-11 2004-12-20 Glaxo Wellcome Sa Morpholino ethers
WO2000024728A1 (en) 1998-10-26 2000-05-04 Merck & Co., Inc. Microbial transformation product
CA2371728C (en) 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6645960B1 (en) 1999-11-11 2003-11-11 Glaxo Wellcome S.A. Antifungal sordaricin derivatives
AU2001289063A1 (en) * 2000-09-15 2002-03-26 Bristol-Myers Squibb Company Novel thio derivatives of sordarin as antifungal agents
CA2434302A1 (en) 2001-01-08 2002-08-15 Neorx Corporation Therapeutic and diagnostic compounds, compositions, and methods
WO2003007878A2 (en) 2001-07-18 2003-01-30 Merck & Co., Inc. Antifungal agents of sordarin derivatives
US7045116B2 (en) 2001-12-13 2006-05-16 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
WO2003051889A1 (en) * 2001-12-14 2003-06-26 Merck & Co., Inc. A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
WO2004060903A2 (en) * 2002-12-31 2004-07-22 Nektar Therapeutics Aerosolizable pharmaceutical formulation for fungal infection therapy
US9314524B2 (en) 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US8419948B2 (en) * 2009-11-22 2013-04-16 United Laboratories International, Llc Wastewater treatment
WO2012033427A1 (ru) * 2010-09-08 2012-03-15 Dalin Mikhail Viktorovich Способ лечения микотических инфекций и препарат для его осуществления
RU2630403C2 (ru) * 2016-02-25 2017-09-07 Жанна Владимировна Вараткова Абразивная масса для изготовления инструмента с высокими номерами структуры

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
JP3189443B2 (ja) * 1992-11-20 2001-07-16 萬有製薬株式会社 抗真菌性物質ｂｅ−３１４０５
CZ88499A3 (cs) * 1996-09-12 1999-10-13 Merck And Co., Inc. Kombinace látek s antifungálním účinkem

Also Published As

Publication number Publication date
NO962856L (no) 1996-09-05
SI0753001T1 (en) 1999-12-31
ZA959362B (en) 1996-05-08
AP614A (en) 1997-09-05
ATE184284T1 (de) 1999-09-15
KR100391401B1 (ko) 2003-12-31
SK88496A3 (en) 1997-04-09
OA10303A (en) 1997-10-07
DE69512041D1 (de) 1999-10-14
BG100699A (bg) 1997-02-28
CZ202796A3 (en) 1997-02-12
IS4352A (is) 1996-06-10
RU2152398C1 (ru) 2000-07-10
EP0753001B1 (en) 1999-09-08
GR3031677T3 (en) 2000-02-29
PE49696A1 (es) 1996-12-05
CN1143965A (zh) 1997-02-26
FI962773A (fi) 1996-08-26
HU218611B (hu) 2000-10-28
FI962773A0 (fi) 1996-07-05
CO4520226A1 (es) 1997-10-15
CN1056849C (zh) 2000-09-27
US5952334A (en) 1999-09-14
NO962856D0 (no) 1996-07-05
BR9506473A (pt) 1997-10-07
AP9600824A0 (en) 1996-07-31
AU3980995A (en) 1996-05-31
IL115905A0 (en) 1996-01-31
HUT76292A (en) 1997-07-28
DE69512041T2 (de) 2000-02-03
AU704405B2 (en) 1999-04-22
US5854280A (en) 1998-12-29
WO1996014326A1 (en) 1996-05-17
BG62620B1 (en) 2000-03-31
JPH09508144A (ja) 1997-08-19
NZ296091A (en) 1998-06-26
HU9601865D0 (en) 1996-11-28
TW321644B (es) 1997-12-01
DK0753001T3 (da) 2000-05-08
MX9602563A (es) 1997-05-31
CA2179403A1 (en) 1996-05-17
AR013815A1 (es) 2001-01-31
EE9600117A (et) 1997-04-15
NO307092B1 (no) 2000-02-07
EP0753001A1 (en) 1997-01-15
HK1004222A1 (en) 1998-11-20

Similar Documents

Publication Publication Date Title
ES2137549T3 (es) Derivados antifungicos de sordaridina.
ES2098921T3 (es) Composiciones de cetoconazol de uso topico.
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
SE8904298D0 (sv) New compounds
NO905328D0 (no) Ventilsystem for ekspanderbare pakninger.
AR000813A1 (es) Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas
GB2331988B (en) Polycyclic sulphamate inhibitors or oestrone sulphatase
IT1232482B (it) Sistema di valvole,ad esempio per analizzatori
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
DK0662967T3 (da) Syntese af N-acetyl-neuraminsyrederivater
DE58909116D1 (de) Gasflaschenventil.
ES2174297T3 (es) Nuevos derivados de piranosidos.
MX9200874A (es) Compuestos de una composicion especifica, un procedimiento para su produccion y su uso.
BR9807785A (pt) Processo para a preparação do composto, e, composto
BR9302359A (pt) Composto,processo para sua preparacao,medicamento e uso
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
BR9300250A (pt) Composto,processo para sua preparacao,medicamento e uso
PT796256E (pt) Novos processos de preparacao da ranitidina
MX9206365A (es) Tetrahidrobenzotienopiridinas,proceso para su preparacion y composicion farmaceutica que las contiene
FI934468A (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytes mellanprodukter
FI945414A0 (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 753001

Country of ref document: ES